A Patient with Beta-Propeller Protein-Associated Neurodegeneration (BPAN): Treatment with Iron Chelation Therapy
활용도 Analysis
논문 Analysis
연구자 Analysis
'
A Patient with Beta-Propeller Protein-Associated Neurodegeneration (BPAN): Treatment with Iron Chelation Therapy' 의 참고문헌
Treatable inherited rare movement disorders
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Patient affected by beta-propeller protein-associated neurodegeneration: a therapeutic attempt with iron chelation therapy
Neuropathology of beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy
Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial
High frequency of beta-propeller proteinassociated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism
Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, Xlinked dominant form of NBIA
Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up
Beta-propeller protein-associated neurodegeneration
Beta propellar protein-associated neurodegeneration: a rare cause of infantile autistic regression and intracranial calcification
'
A Patient with Beta-Propeller Protein-Associated Neurodegeneration (BPAN): Treatment with Iron Chelation Therapy'
의 유사주제(
